Induced pluripotent stem cells (iPSCs) and neurological disease modeling: Progress and promises

Human Molecular Genetics

Volumn 20, Issue R2, 2011, Pages 109-115

  Marchetto, Maria C ^a   Brennand, Kristen J ^a   Boyer, Leah F ^a   Gage, Fred H ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; DYSAUTONOMIA; FIBROBLAST; FRAGILE X SYNDROME; GENE MUTATION; HUMAN; NERVE CELL; NONHUMAN; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RETT SYNDROME; SCHIZOPHRENIA; SOMATIC CELL; SPINAL MUSCULAR ATROPHY; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; GENETICS; METABOLISM; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, BIOLOGICAL; NERVOUS SYSTEM DISEASES; NEURONS;

EID: 80155144126     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr336     Document Type: Article

References (68)

1. Takahashi, K. and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
2. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861-872.
3. Ebert, A.D., Yu, J., Rose, F.F. Jr, Mattis, V.B., Lorson, C.L., Thomson, J.A. and Svendsen, C.N. (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature, 457, 277-280.
4. Lee, G., Papapetrou, E.P., Kim, H., Chambers, S.M., Tomishima, M.J., Fasano, C.A., Ganat, Y.M., Menon, J., Shimizu, F., Viale, A. et al. (2009) Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature, 461, 402-406.
5. Soldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G.W., Cook, E.G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M. et al. (2009) Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 136, 964-977.
6. Park, I.H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M.W., Cowan, C., Hochedlinger, K. and Daley, G.Q. (2008) Disease-specific induced pluripotent stem cells. Cell, 134, 877-886.
7. Hargus, G., Cooper, O., Deleidi, M., Levy, A., Lee, K., Marlow, E., Yow, A., Soldner, F., Hockemeyer, D., Hallett, P.J. et al. (2010) Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc. Natl Acad. Sci. USA, 107, 15921-15926.
8. Nguyen, H.N., Byers, B., Cord, B., Shcheglovitov, A., Byrne, J., Gujar, P., Kee, K., Schule, B., Dolmetsch, R.E., Langston, W. et al. (2011) LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell, 8, 267-280.
9. Seibler, P., Graziotto, J., Jeong, H., Simunovic, F., Klein, C. and Krainc, D. (2011) Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J. Neurosci., 31, 5970-5976.
10. Wicklund, L., Leao, R.N., Stromberg, A.M., Mousavi, M., Hovatta, O., Nordberg, A. and Marutle, A. (2010) Beta-amyloid 1-42 oligomers impair function of human embryonic stem cell-derived forebrain cholinergic neurons. PLoS One, 5, e15600.
11. Rosen, D.R. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 364, 362.
12. Nishimura, A.L., Mitne-Neto, M., Silva, H.C., Richieri-Costa, A., Middleton, S., Cascio, D., Kok, F., Oliveira, J.R., Gillingwater, T., Webb, J. et al. (2004) A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet., 75, 822-831.
13. Dimos, J.T., Rodolfa, K.T., Niakan, K.K., Weisenthal, L.M., Mitsumoto, H., Chung, W., Croft, G.F., Saphier, G., Leibel, R., Goland, R. et al. (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science, 321, 1218-1221.
14. Mitne-Neto, M., Machado-Costa, M., Marchetto, M.C., Bengtson, M.H., Joazeiro, C.A., Tsuda, H., Bellen, H.J., Silva, H.C., Oliveira, A.S., Lazar, M. et al. (2011) Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum. Mol. Genet., doi:10.1093/hmg/ddr284.
15. Anagnostou, G., Akbar, M.T., Paul, P., Angelinetta, C., Steiner, T.J. and de Belleroche, J. (2010) Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord. Neurobiol. Aging, 31, 969-985.
16. Clement, A.M., Nguyen, M.D., Roberts, E.A., Garcia, M.L., Boillee, S., Rule, M., McMahon, A.P., Doucette, W., Siwek, D., Ferrante, R.J. et al. (2003) Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science, 302, 113-117.
17. Nagai, M., Re, D.B., Nagata, T., Chalazonitis, A., Jessell, T.M., Wichterle, H. and Przedborski, S. (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci., 10, 615-622.
18. Di Giorgio, F.P., Boulting, G.L., Bobrowicz, S. and Eggan, K.C. (2008) Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell, 3, 637-648.
19. Marchetto, M.C., Muotri, A.R., Mu, Y., Smith, A.M., Cezar, G.G. and Gage, F.H. (2008) Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell, 3, 649-657.
20. Mitchell, K.J. (2011) The genetics of neurodevelopmental disease. Curr. Opin. Neurobiol., 21, 197-203.
21. Autism, Developmental Disabilities Monitoring Network Surveillance Year Principal Investigators, Centers for Disease Control and Prevention. (2007) Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, six sites, United States, 2000. MMWR Surveill. Summ., 56, 1-11.
22. Autism, Developmental Disabilities Monitoring Network Surveillance Year Principal Investigators, Centers for Disease Control and Prevention (2009) Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill. Summ., 58, 1-20.
23. Chen, Y.J., Zhang, M., Yin, D.M., Wen, L., Ting, A., Wang, P., Lu, Y.S., Zhu, X.H., Li, S.J., Wu, C.Y. et al. (2010) ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation. Proc. Natl Acad. Sci. USA, 107, 21818-21823.
24. Cheung, A.Y., Horvath, L.M., Grafodatskaya, D., Pasceri, P., Weksberg, R., Hotta, A., Carrel, L. and Ellis, J. (2011) Isolation of MECP2-null Rett syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum. Mol. Genet., 20, 2103-2115.
25. Chen, R.Z., Akbarian, S., Tudor, M. and Jaenisch, R. (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet., 27, 327-331.
26. Tropea, D., Giacometti, E., Wilson, N.R., Beard, C., McCurry, C., Fu, D.D., Flannery, R., Jaenisch, R. and Sur, M. (2009) Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice. Proc. Natl Acad. Sci. USA, 106, 2029-2034.
27. Marchetto, M.C., Carromeu, C., Acab, A., Yu, D., Yeo, G.W., Mu, Y., Chen, G., Gage, F.H. and Muotri, A.R. (2010) A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell, 143, 527-539.
28. Muotri, A.R., Marchetto, M.C., Coufal, N.G., Oefner, R., Yeo, G., Nakashima, K. and Gage, F.H. (2010) L1 retrotransposition in neurons is modulated by MeCP2. Nature, 468, 443-446.
29. Oberle, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boue, J., Bertheas, M.F. and Mandel, J.L. (1991) Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science, 252, 1097-1102.
30. Coffee, B., Zhang, F., Warren, S.T. and Reines, D. (1999) Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat. Genet., 22, 98-101.
31. Eiges, R., Urbach, A., Malcov, M., Frumkin, T., Schwartz, T., Amit, A., Yaron, Y., Eden, A., Yanuka, O., Benvenisty, N. et al. (2007) Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell, 1, 568-577.
32. Urbach, A., Bar-Nur, O., Daley, G.Q. and Benvenisty, N. (2010) Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell, 6, 407-411.
33. Koenen, K.C., Moffitt, T.E., Roberts, A.L., Martin, L.T., Kubzansky, L., Harrington, H., Poulton, R. and Caspi, A. (2009) Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. Am. J. Psychiatry, 166, 50-57.
34. Chiang, C.H., Su, Y., Wen, Z., Yoritomo, N., Ross, C.A., Margolis, R.L., Song, H. and Ming, G.L. (2011) Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol. Psychiatry, 16, 358-360.
35. Brennand, K.J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D. et al. (2011) Modelling schizophrenia using human induced pluripotent stem cells. Nature, 473, 221-225. doi:10.1038/nature09915.
36. Kataoka, Y., Kalanithi, P.S., Grantz, H., Schwartz, M.L., Saper, C., Leckman, J.F. and Vaccarino, F.M. (2010) Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J. Comp. Neurol., 518, 277-291.
37. Caspi, A., Sugden, K., Moffitt, T.E., Taylor, A., Craig, I.W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A. et al. (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science, 301, 386-389.
38. Nestler, E.J. (2005) Is there a common molecular pathway for addiction? Nat. Neurosci., 8, 1445-1449.
39. Mayshar, Y., Ben-David, U., Lavon, N., Biancotti, J.C., Yakir, B., Clark, A.T., Plath, K., Lowry, W.E. and Benvenisty, N. (2010) Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell, 7, 521-531.
40. Bruck, T. and Benvenisty, N. (2011) Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells. Stem Cell Res., 6, 187-193.
41. Pick, M., Stelzer, Y., Bar-Nur, O., Mayshar, Y., Eden, A. and Benvenisty, N. (2009) Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells, 27, 2686-2690.
42. Lister, R., Pelizzola, M., Kida, Y.S., Hawkins, R.D., Nery, J.R., Hon, G., Antosiewicz-Bourget, J., O'Malley, R., Castanon, R., Klugman, S. et al. (2011) Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature, 471, 68-73.
43. Gore, A., Li, Z., Fung, H.L., Young, J.E., Agarwal, S., Antosiewicz-Bourget, J., Canto, I., Giorgetti, A., Israel, M.A., Kiskinis, E. et al. (2011) Somatic coding mutations in human induced pluripotent stem cells. Nature, 471, 63-67.
44. Hussein, S.M., Batada, N.N., Vuoristo, S., Ching, R.W., Autio, R., Narva, E., Ng, S., Sourour, M., Hamalainen, R., Olsson, C. et al. (2011) Copy number variation and selection during reprogramming to pluripotency. Nature, 471, 58-62.
45. Hu, B.Y., Weick, J.P., Yu, J., Ma, L.X., Zhang, X.Q., Thomson, J.A. and Zhang, S.C. (2010) Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl Acad. Sci. USA, 107, 4335-4340.
46. Boulting, G.L., Kiskinis, E., Croft, G.F., Amoroso, M.W., Oakley, D.H., Wainger, B.J., Williams, D.J., Kahler, D.J., Yamaki, M., Davidow, L. et al. (2011) A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol., 29, 279-286.
47. Zhou, H., Wu, S., Joo, J.Y., Zhu, S., Han, D.W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y. et al. (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell, 4, 381-384.
48. Marchetto, M.C., Yeo, G.W., Kainohana, O., Marsala, M., Gage, F.H. and Muotri, A.R. (2009) Transcriptional signature and memory retention of human-induced pluripotent stem cells. PLoS One, 4, e7076.
49. Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, II. and Thomson, J.A. (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324, 797-801.
50. Warren, L., Manos, P.D., Ahfeldt, T., Loh, Y.H., Li, H., Lau, F., Ebina, W., Mandal, P.K., Smith, Z.D., Meissner, A. et al. (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7, 618-630.
51. Ladewig, J., Koch, P., Endl, E., Meiners, B., Opitz, T., Couillard-Despres, S., Aigner, L. and Brustle, O. (2008) Lineage selection of functional and cryopreservable human embryonic stem cell-derived neurons. Stem Cells, 26, 1705-1712.
52. Ruby, K.M. and Zheng, B. (2009) Gene targeting in a HUES line of human embryonic stem cells via electroporation. Stem Cells, 27, 1496-1506.
53. Hedlund, E., Pruszak, J., Ferree, A., Vinuela, A., Hong, S., Isacson, O. and Kim, K.S. (2007) Selection of embryonic stem cell-derived enhanced green fluorescent protein-positive dopamine neurons using the tyrosine hydroxylase promoter is confounded by reporter gene expression in immature cell populations. Stem Cells, 25, 1126-1135.
54. Pruszak, J., Sonntag, K.C., Aung, M.H., Sanchez-Pernaute, R. and Isacson, O. (2007) Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations. Stem Cells, 25, 2257-2268.
55. Yuan, S.H., Martin, J., Elia, J., Flippin, J., Paramban, R.I., Hefferan, M.P., Vidal, J.G., Mu, Y., Killian, R.L., Israel, M.A. et al. (2011) Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS One, 6, e17540.
56. Chambers, S.M., Fasano, C.A., Papapetrou, E.P., Tomishima, M., Sadelain, M. and Studer, L. (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol., 27, 275-280.
57. Cooper, O., Hargus, G., Deleidi, M., Blak, A., Osborn, T., Marlow, E., Lee, K., Levy, A., Perez-Torres, E., Yow, A. et al. (2010) Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acid. Mol. Cell. Neurosci., 45, 258-266.
58. Bissonnette, C.J., Lyass, L., Bhattacharyya, B.J., Belmadani, A., Miller, R.J. and Kessler, J.A. (2011) The controlled generation of functional basal forebrain cholinergic neurons from human embryonic stem cells. Stem Cells, 29, 802-811.
59. Eiraku, M., Watanabe, K., Matsuo-Takasaki, M., Kawada, M., Yonemura, S., Matsumura, M., Wataya, T., Nishiyama, A., Muguruma, K. and Sasai, Y. (2008) Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell, 3, 519-532.
60. Oblak, A.L., Rosene, D.L., Kemper, T.L., Bauman, M.L. and Blatt, G.J. (2011) Altered posterior cingulate cortical cyctoarchitecture, but normal density of neurons and interneurons in the posterior cingulate cortex and fusiform gyrus in autism. Autism Res., 4, 200-211.
61. Kim, S. and Webster, M.J. (2010) Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol. Psychiatry, 15, 326-336.
62. Wissner-Gross, Z.D., Scott, M.A., Ku, D., Ramaswamy, P. and Fatih Yanik, M. (2011) Large-scale analysis of neurite growth dynamics on micropatterned substrates. Integr Biol (Camb), 3, 65-74.
63. Taylor, A.M., Blurton-Jones, M., Rhee, S.W., Cribbs, D.H., Cotman, C.W. and Jeon, N.L. (2005) A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat. Methods, 2, 599-605.
64. Berninger, B., Costa, M.R., Koch, U., Schroeder, T., Sutor, B., Grothe, B. and Gotz, M. (2007) Functional properties of neurons derived from in vitro reprogrammed postnatal astroglia. J. Neurosci., 27, 8654-8664.
65. Vierbuchen, T., Ostermeier, A., Pang, Z.P., Kokubu, Y., Sudhof, T.C. and Wernig, M. (2010) Direct conversion of fibroblasts to functional neurons by defined factors. Nature, 463, 1035-1041.
66. Pfisterer, U., Kirkeby, A., Torper, O., Wood, J., Nelander, J., Dufour, A., Bjorklund, A., Lindvall, O., Jakobsson, J. and Parmar, M. (2011) Direct conversion of human fibroblasts to dopaminergic neurons. Proc. Natl Acad. Sci. USA, 108, 10343-10348.
67. Caiazzo, M., Dell'anno, M.T., Dvoretskova, E., Lazarevic, D., Taverna, S., Leo, D., Sotnikova, T.D., Menegon, A., Roncaglia, P., Colciago, G. et al. (2011) Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature, doi:10.1038/ nature10284.
68. Soldner, F., Laganie're, J., Cheng, A.W., Hockemeyer, D., Gao, Q., Alagappan, R., Khurana, V., Golbe, L.I., Myers, R.H., Lindquist, S. et al. (2011) Cell, 146, 318-331. Epub ahead of print July 14, 2011.